BlazingStocks
6 minutes ago
$COEP - "By leveraging specific sites, we aim to enable GEAR-modified immune cells, NK cells in this instance, to be co-administered in combination with antibodies in a manner that largely avoids undesired ‘on target/off tumor effects’ on a plethora of combination or retargeting therapies."https://f